Efficacy of timing‑dependent infusion of nivolumab in patients with advanced gastric cancer-Reference-Cited by-同舟云学术

Efficacy of timing‑dependent infusion of nivolumab in patients with advanced gastric cancer

Published:2024-07-29 Issue:4 Volume:28 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Tanaka Toshimitsu¹,Suzuki Hiroyuki²,Yamaguchi Shotaro¹,Shimotsuura Yasutaka¹,Nagasu Sachiko²,Murotani Kenta³,Fujita Fumihiko⁴,Kawaguchi Takumi²,Miwa Keisuke¹

Affiliation:

1. Multidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume, Fukuoka 830‑0011, Japan

2. Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830‑0011, Japan

3. Biostatistics Center, Kurume University, Kurume, Fukuoka 830‑0011, Japan

4. Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka 830‑0011, Japan

Publisher

Spandidos Publications

Reference37 articles.

1. Cancer immunotherapy comes of age;Mellman;Nature,2011

2. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial;Kang;Lancet,2017

3. A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2);Kato;Gastric Cancer,2019

4. Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis;Gao;J Cell Mol Med,2023

5. Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: A randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer;Satoh;Gastric Cancer,2020